---
figid: PMC5140697__nihms827176f2
figtitle: 'Targeting cancer metabolism: dietary and pharmacological interventions'
organisms:
- Homo sapiens
- Mus musculus
- Rattus norvegicus
- Macaca mulatta
organisms_ner:
- Rattus norvegicus
- Macaca mulatta
- Mus musculus
- Homo sapiens
- Drosophila melanogaster
pmcid: PMC5140697
filename: nihms827176f2.jpg
figlink: /pmc/articles/PMC5140697/figure/F2/
number: F2
caption: 'Insulin receptor (IR) and IGF-1 receptor (IGF-1R) can either homo- or heterodimerize
  to activate their TK domains; this stimulates downstream RAS/RAF/MEK/ERK and RAS/PI3K/AKT/mTOR
  signal transduction pathways, which induce survival, proliferation, angiogenesis
  and ribosomal synthesis of several proteins, including hypoxia-induced factor 1α
  (HIF-1α). PI3K, RAS and HIF-1α promote crucial metabolic modifications in neoplastic
  cells, including glucose uptake and aerobic glycolysis, as well as de novo synthesis
  of fatty acids. Since RAS/RAF/MEK/ERK and RAS/PI3K/AKT/mTOR cascades can also be
  activated by other membrane receptors, including EGFR and HER2, combining inhibition
  of IGF-1/IGF-1R pathway with targeting of other TK receptors or their downstream
  mediators (e.g. mTOR) could synergistically inhibit cancer cell proliferation and
  survival.Abbreviations. EGFR: epidermal growth factor receptor; HER2: human epidermal
  growth factor receptor 2; HIF1-α: hypoxia-induced factor 1-α; IGF-1: insulin-like
  growth factor 1; IGFBPs: IGF-1 binding proteins; IGF-1R: IGF-1 receptor; IR: insulin
  receptor; mTOR: mammalian target of rapamycin; PI3K: phosphoinositide 3-kinase;
  S6K: S6 kinase.'
papertitle: 'Targeting cancer metabolism: dietary and pharmacological interventions.'
reftext: Claudio Vernieri, et al. Cancer Discov. ;6(12):1315-1333.
year: ''
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9617072
figid_alias: PMC5140697__F2
figtype: Figure
redirect_from: /figures/PMC5140697__F2
ndex: a667dbe6-de9c-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5140697__nihms827176f2.html
  '@type': Dataset
  description: 'Insulin receptor (IR) and IGF-1 receptor (IGF-1R) can either homo-
    or heterodimerize to activate their TK domains; this stimulates downstream RAS/RAF/MEK/ERK
    and RAS/PI3K/AKT/mTOR signal transduction pathways, which induce survival, proliferation,
    angiogenesis and ribosomal synthesis of several proteins, including hypoxia-induced
    factor 1α (HIF-1α). PI3K, RAS and HIF-1α promote crucial metabolic modifications
    in neoplastic cells, including glucose uptake and aerobic glycolysis, as well
    as de novo synthesis of fatty acids. Since RAS/RAF/MEK/ERK and RAS/PI3K/AKT/mTOR
    cascades can also be activated by other membrane receptors, including EGFR and
    HER2, combining inhibition of IGF-1/IGF-1R pathway with targeting of other TK
    receptors or their downstream mediators (e.g. mTOR) could synergistically inhibit
    cancer cell proliferation and survival.Abbreviations. EGFR: epidermal growth factor
    receptor; HER2: human epidermal growth factor receptor 2; HIF1-α: hypoxia-induced
    factor 1-α; IGF-1: insulin-like growth factor 1; IGFBPs: IGF-1 binding proteins;
    IGF-1R: IGF-1 receptor; IR: insulin receptor; mTOR: mammalian target of rapamycin;
    PI3K: phosphoinositide 3-kinase; S6K: S6 kinase.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Igf1
  - Igf1r
  - Egfr
  - Pik3cg
  - Map2k1
  - Akt1
  - Mapk3
  - Mapk1
  - Mtor
  - Hif1a
  - IGF1
  - IGF1R
  - EGFR
  - MTOR
  - HIF1A
  - .na.character
  - Erbb2
  - ras
  - Hras
  - Kras
  - Rem1
  - Zhx2
  - Pik3r1
  - Map2k2
  - Rps6kb1
  - ERBB2
  - KRAS
  - HRAS
  - NRAS
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - MAP2K1
  - MAP2K2
  - AKT1
  - AKT2
  - AKT3
  - MAPK3
  - MAPK1
  - RPS6KB1
  - Low
  - Ras64B
  - Ras85D
  - de
  - Raf
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Dsor1
  - Akt
  - rl
  - Tor
  - S6k
  - sima
  - Temsirolimus
  - arginine
  - Fatty acid
  - Glucose
  - glutamine
  - leucine
  - Metformin
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
---
